Evidence map›Paper›PMID 31064116›Full record

ArticleInternational journal of molecular sciences2019

Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.

Joseph Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Cellular basis of HFpEF: contributions of abnormal lipids.Frontiers in cardiovascular medicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. A new classification of cardio-oncology syndromes.Cardio-oncology (London, England) · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph Pierre AboumsallemCentre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium. josephpierre.aboumsallem@kuleuven.be.ORCID 0000-0001-8186-6620
Ilayaraja MuthuramuCentre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium. illas1985@gmail.com.ORCID 0000-0003-3550-7672
Mudit MishraCentre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium. mudit.mishra@kuleuven.be.
Bart De GeestCentre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium. bart.degeest@kuleuven.be.ORCID 0000-0001-5580-686X
KU Leuven · BE

Funding

Fonds voor Wetenschappelijk Onderzoek-Vlaanderen G0A3114NOnderzoekstoelagen grant KU Leuven OT/13/090
6 · The paper itself

Abstract

Hypercholesterolemia may be causally related to heart failure with preserved ejection fraction (HFpEF). We aimed to establish a HFpEF model associated with hypercholesterolemia and type 2 diabetes mellitus by feeding a high-sucrose/high-fat (HSHF) diet to C57BL/6J low-density lipoprotein receptor (LDLr)

Indexed as

AnimalsCholesterolDependovirusDiabetes Mellitus, Type 2Diabetic CardiomyopathiesDietary SucroseDiet, High-FatFemaleGenetic TherapyHeart FailureHypercholesterolemiaMiceMice, Inbred C57BLOxidative StressReceptors, LDLStroke VolumeCholesterolDietary SucroseReceptors, LDLTumor Necrosis Factor-alphagene therapyheart failure with preserved ejection fractionhypercholesterolemiaoxidative stresstype 2 diabetes

Identifiers

PMID31064116
PMCPMC6539537
OpenAlexW2943300148

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.